Bone Turnover Markers After Sleep Restriction and Circadian Disruption: A Mechanism for Sleep-Related Bone Loss in Humans
-
2017/10/01
-
Details
-
Personal Author:Buxton OM ; Cain SW ; Czeisler, Charles A. ; Munch M ; Orwoll ES ; Shea SA ; Swanson CM ; Vujovic N ; Wolfe P
-
Description:Context: Sleep abnormalities are associated with low bone mineral density. Underlying mechanisms are unknown. Objective: Investigate the impact of sleep restriction with circadian disruption on bone biomarkers. Design: Intervention study. Participants and Methods: Four bone biomarkers [C-terminal cross-linked telopeptide of type I collagen (CTX) = bone resorption, N-terminal propeptide of type I procollagen (P1NP) = bone formation, sclerostin and fibroblast growth factor 23 = osteocyte function] were measured in bihourly serum samples over 24 hours at baseline and after approximately 3 weeks of sleep restriction (5.6 hours sleep/24 hours) with concurrent circadian disruption (recurring 28-hour "day" in dim light) in 10 men (age groups: 20 to 27 years, n = 6; 55 to 65 years, n = 4). The effects of sleep/circadian disruption and age on bone biomarker levels were evaluated using maximum likelihood estimation in a mixed model for repeated measures. Results: P1NP levels were lower after intervention compared with baseline (P < 0.001); the decrease in P1NP was greater for younger compared with older men (28.0% vs 18.2%, P < 0.001). There was no change in CTX (delta = 0.03 +/- 0.02 ng/mL, P = 0.10). Sclerostin levels were higher postintervention in the younger men only (delta = 22.9% or 5.64 +/- 1.10 pmol/L, P < 0.001). Conclusions: These data suggest that 3 weeks of circadian disruption with concurrent sleep restriction can lead to an uncoupling of bone turnover wherein bone formation is decreased but bone resorption is unchanged. Circadian disruption and sleep restriction may be most detrimental to bone in early adulthood. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0021-972X
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Topic:
-
Location:
-
Volume:102
-
Issue:10
-
NIOSHTIC Number:nn:20050567
-
Citation:J Clin Endocrinol Metab 2017 Oct; 102(10):3722-3730
-
Contact Point Address:Christine M. Swanson, MD, Division of Endocrinology, University of Colorado, 12801 E. 17th Avenue, Mail Stop 8106, Aurora, Colorado 80045
-
Email:Christine.Swanson@UCDenver.edu
-
Federal Fiscal Year:2018
-
NORA Priority Area:
-
Performing Organization:Oregon Health & Science University, Portland
-
Peer Reviewed:True
-
Start Date:20110901
-
Source Full Name:Journal of Clinical Endocrinology and Metabolism
-
End Date:20260831
-
Collection(s):
-
Main Document Checksum:urn:sha-512:33c14c59f73d20c72a674ae36a00cd28d656460cd0c671f042a034a54859380406f8ff35c176c03594024ac98fe39ec89bd498dd6f8612ce24a9b3ccda4d5ce6
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like